Synergistic effect of Hsp90 inhibitor ginkgolic acids C15 ꞉1 combined with paclitaxel on nasopharyngeal carcinoma.
10.11817/j.issn.1672-7347.2023.230061
- Author:
Hui MA
1
;
Di HUANG
2
;
Bohan LI
2
;
Feng DING
2
;
Hongmei LI
2
;
Chengzhu WU
3
Author Information
1. School of Pharmacy, Bengbu Medical College, Bengbu Anhui 233030. mahui9513@foxmail.com.
2. School of Pharmacy, Bengbu Medical College, Bengbu Anhui 233030.
3. School of Pharmacy, Bengbu Medical College, Bengbu Anhui 233030. wuchengzhu0611@bbmc.edu.cn.
- Publication Type:Journal Article
- Keywords:
anti-tumor effect;
ginkgolic acids C15꞉1;
heat shock protein 90 inhibitor;
nasopharyngeal carcinoma;
paclitaxel;
synergistic effect
- MeSH:
Humans;
Nasopharyngeal Carcinoma;
Paclitaxel/therapeutic use*;
Nasopharyngeal Neoplasms/metabolism*;
Antineoplastic Agents/therapeutic use*;
Apoptosis;
Cell Proliferation;
Cell Line, Tumor
- From:
Journal of Central South University(Medical Sciences)
2023;48(8):1128-1135
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Nasopharyngeal cracinoma is a kind of head and neck malignant tumor with high incidence and high mortality. Due to the characteristics of local recurrence, distant metastasis, and drug resistance, the survival rate of patients after treatment is not high. Paclitaxel (PTX) is used as a chemotherapy drug in treating nasopharyngeal carcinoma, but nasopharyngeal carcinoma cells are easy to develop resistance to PTX. Inhibition of heat shock protein 90 (Hsp90) can overcome common signal redundancy and resistance in many cancers. This study aims to investigate the anti-tumor effect of ginkgolic acids C15꞉1 (C15:1) combined with PTX on nasopharyngeal carcinoma CNE-2Z cells and the mechanisms.
METHODS:This experiment was divided into a control group (without drug), a C15:1 group (10, 30, 50, 70 μmol/L), a PTX group (5, 10, 20, 40 nmol/L), and a combination group. CNE-2Z cells were treated with the corresponding drugs in each group. The proliferation of CNE-2Z cells was evaluated by methyl thiazolyl tetrazolium (MTT). Wound-healing assay and transwell chamber assay were used to determine the migration of CNE-2Z cells. Transwell chamber was applied to the impact of CNE-2Z cell invasion. Annexin V-FITC/PI staining was used to observe the effect on apoptosis of CNE-2Z cells. The changes of proteins involved in cell invasion, migration, and apoptosis after the combination of C15꞉1 and PTX treatment were analyzed by Western blotting.
RESULTS:Compared with the control group, the C15꞉1 group and the PTX group could inhibit the proliferation of CNE-2Z cells (all P<0.05). The cell survival rates of the C15꞉1 50 μmol/L combined with 5, 10, 20, or 40 nmol/L PTX group were lower than those of the single PTX group (all P<0.05), the combination index (CI) value was less than 1, suggesting that the combined treatment group had a synergistic effect. Compared with the 50 μmol/L C15꞉1 group and the 10 nmol/L PTX group, the combination group significantly inhibited the invasion and migration of CNE-2Z cells (all P<0.05). The results of Western blotting demonstrated that the combination group could significantly down-regulate Hsp90 client protein matrix metalloproteinase (MMP)-2 and MMP-9. The results of double staining showed that compared with the 50 μmol/L C15꞉1 group and the 10 nmol/L PTX group, the apoptosis ratio of CNE-2Z cells in the combination group was higher (both P<0.05). The results of Western blotting suggested that the combination group could decrease the Hsp90 client proteins [Akt and B-cell lymphoma-2 (Bcl-2)] and increase the Bcl-2-associated X protein (Bax).
CONCLUSIONS:The combination of C15꞉1 and PTX has a synergistic effect which can inhibit cell proliferation, invasion, and migration, and induce cell apoptosis. This effect may be related to the inhibition of Hsp90 activity by C15꞉1.
